Evidence map›Paper›PMID 37973344›Full record

SynthesisThe Lancet. Global health2023

Health financing policies during the COVID-19 pandemic and implications for universal health care: a case study of 15 countries.

Chuan De Foo, Monica Verma, Si Ying Tan, Jess Hamer, Nina van der Mark, Aungsumalee Pholpark, Piya Hanvoravongchai, Paul Li Jen Cheh, Tiara Marthias, Yodi Mahendradhata and 14 more

Abstract readSystematic Review
In one paragraph

Synthesis in The Lancet. Global health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Governance in Crisis: A Mixed-Methods Analysis of Global Health Governance During COVID-19.International journal of environmental research and public health · 2025
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Chuan De FooSaw Swee Hock School of Public Health, National University of Singapore, Singapore; Duke NUS Graduate Medical School, Singapore. Electronic address: ephfchu@nus.edu.sg.
Monica VermaSaw Swee Hock School of Public Health, National University of Singapore, Singapore.
Si Ying TanSaw Swee Hock School of Public Health, National University of Singapore, Singapore.
Jess HamerCentre for Universal Health, Chatham House, London, UK.
Nina van der MarkCentre for Universal Health, Chatham House, London, UK.
Aungsumalee PholparkFaculty of Social Sciences and Humanities, Mahidol University, Nakhon Pathom, Thailand.
Piya HanvoravongchaiNational Health Foundation, Bangkok, Thailand; Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Paul Li Jen ChehNational Health Foundation, Bangkok, Thailand.
Tiara MarthiasDepartment of Health Policy and Management, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia; Nossal Institute for Global Health, The University of Melbourne, Melbourne, VIC, Australia.
Yodi MahendradhataDepartment of Health Policy and Management, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.
Likke Prawidya PutriDepartment of Health Policy and Management, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.
Firdaus HafidzDepartment of Health Policy and Management, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.
Kim Bao GiangSchool of Preventive Medicine and Public Health, Hanoi Medical University, Hanoi, Viet Nam.
Thi Hong Hanh KhucSchool of Preventive Medicine and Public Health, Hanoi Medical University, Hanoi, Viet Nam.
Hoang Van MinhHanoi University of Public Health, Hanoi, Viet Nam.
Shishi WuDalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
Cinthya G Caamal-OlveraUniversidad Autónoma de Nuevo León, Monterrey, Mexico.
Gorka OriveNanoBioCel Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain.
Hong WangBill & Melinda Gates Foundation, Seattle, WA, USA.
Stefan NachukBill & Melinda Gates Foundation, Seattle, WA, USA.
Jeremy LimSaw Swee Hock School of Public Health, National University of Singapore, Singapore.
Valeria de Oliveira CruzSouth-East Asia Regional Office, WHO, New Delhi, India.
Rob YatesCentre for Universal Health, Chatham House, London, UK.
Helena Legido-QuigleySaw Swee Hock School of Public Health, National University of Singapore, Singapore; Imperial College and the George Institute for Global Health, London, UK.

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundThe COVID-19 pandemic was a health emergency requiring rapid fiscal resource mobilisation to support national responses. The use of effective health financing mechanisms and policies, or lack thereof, affected the impact of the pandemic on the population, particularly vulnerable groups and individuals. We provide an overview and illustrative examples of health financing policies adopted in 15 countries during the pandemic, develop a framework for resilient health financing, and use this pandemic to argue a case to move towards universal health coverage (UHC).

methodsIn this case study, we examined the national health financing policy responses of 15 countries, which were purposefully selected countries to represent all WHO regions and have a range of income levels, UHC index scores, and health system typologies. We did a systematic literature review of peer-reviewed articles, policy documents, technical reports, and publicly available data on policy measures undertaken in response to the pandemic and complemented the data obtained with 61 in-depth interviews with health systems and health financing experts. We did a thematic analysis of our data and organised key themes into a conceptual framework for resilient health financing.

findingsResilient health financing for health emergencies is characterised by two main phases: (1) absorb and recover, where health systems are required to absorb the initial and subsequent shocks brought about by the pandemic and restabilise from them; and (2) sustain, where health systems need to expand and maintain fiscal space for health to move towards UHC while building on resilient health financing structures that can better prepare health systems for future health emergencies. We observed that five key financing policies were implemented across the countries-namely, use of extra-budgetary funds for a swift initial response, repurposing of existing funds, efficient fund disbursement mechanisms to ensure rapid channelisation to the intended personnel and general population, mobilisation of the private sector to mitigate the gaps in public settings, and expansion of service coverage to enhance the protection of vulnerable groups. Accountability and monitoring are needed at every stage to ensure efficient and accountable movement and use of funds, which can be achieved through strong governance and coordination, information technology, and community engagement.

interpretationOur findings suggest that health systems need to leverage the COVID-19 pandemic as a window of opportunity to make health financing policies robust and need to politically commit to public financing mechanisms that work to prepare for future emergencies and as a lever for UHC.

fundingBill & Melinda Gates Foundation.

Indexed as

COVID-19PandemicsEmergenciesHealthcare FinancingHealth PolicyHumansUniversal Health Care

Identifiers

PMID37973344
PMCPMC10664823

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.